193 related articles for article (PubMed ID: 36475772)
1. Impact of Growth Rate on the Protein-mRNA Ratio in Pseudomonas aeruginosa.
Zhang M; Michie KL; Cornforth DM; Dolan SK; Wang Y; Whiteley M
mBio; 2023 Feb; 14(1):e0306722. PubMed ID: 36475772
[TBL] [Abstract][Full Text] [Related]
2.
Neff SL; Doing G; Reiter T; Hampton TH; Greene CS; Hogan DA
Microbiol Spectr; 2024 Apr; 12(4):e0315723. PubMed ID: 38385740
[TBL] [Abstract][Full Text] [Related]
3. Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung.
Gifford AH; Willger SD; Dolben EL; Moulton LA; Dorman DB; Bean H; Hill JE; Hampton TH; Ashare A; Hogan DA
Infect Immun; 2016 Oct; 84(10):2995-3006. PubMed ID: 27481238
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome Analysis of Pseudomonas aeruginosa Biofilm Infection in an
Harrington NE; Littler JL; Harrison F
Appl Environ Microbiol; 2022 Feb; 88(3):e0178921. PubMed ID: 34878811
[TBL] [Abstract][Full Text] [Related]
5.
Cornforth DM; Dees JL; Ibberson CB; Huse HK; Mathiesen IH; Kirketerp-Møller K; Wolcott RD; Rumbaugh KP; Bjarnsholt T; Whiteley M
Proc Natl Acad Sci U S A; 2018 May; 115(22):E5125-E5134. PubMed ID: 29760087
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients.
Son MS; Matthews WJ; Kang Y; Nguyen DT; Hoang TT
Infect Immun; 2007 Nov; 75(11):5313-24. PubMed ID: 17724070
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections.
Davis TJ; Karanjia AV; Bhebhe CN; West SB; Richardson M; Bean HD
mSphere; 2020 Oct; 5(5):. PubMed ID: 33028687
[No Abstract] [Full Text] [Related]
8. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
Vermilyea DM; Crocker AW; Gifford AH; Hogan DA
J Bacteriol; 2021 Jun; 203(13):e0010021. PubMed ID: 33927050
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa Proteome under Hypoxic Stress Conditions Mimicking the Cystic Fibrosis Lung.
Kamath KS; Krisp C; Chick J; Pascovici D; Gygi SP; Molloy MP
J Proteome Res; 2017 Oct; 16(10):3917-3928. PubMed ID: 28832155
[TBL] [Abstract][Full Text] [Related]
10. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis.
Kenna DT; Doherty CJ; Foweraker J; Macaskill L; Barcus VA; Govan JRW
Microbiology (Reading); 2007 Jun; 153(Pt 6):1852-1859. PubMed ID: 17526842
[TBL] [Abstract][Full Text] [Related]
11. Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients.
Barthe C; Nandakumar S; Derlich L; Macey J; Bui S; Fayon M; Crouzet M; Garbay B; Vilain S; Costaglioli P
Lett Appl Microbiol; 2015 Nov; 61(5):423-8. PubMed ID: 26174137
[TBL] [Abstract][Full Text] [Related]
12. The Staphylococcus aureus Transcriptome during Cystic Fibrosis Lung Infection.
Ibberson CB; Whiteley M
mBio; 2019 Nov; 10(6):. PubMed ID: 31744924
[TBL] [Abstract][Full Text] [Related]
13. Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.
Kragh KN; Alhede M; Jensen PØ; Moser C; Scheike T; Jacobsen CS; Seier Poulsen S; Eickhardt-Sørensen SR; Trøstrup H; Christoffersen L; Hougen HP; Rickelt LF; Kühl M; Høiby N; Bjarnsholt T
Infect Immun; 2014 Nov; 82(11):4477-86. PubMed ID: 25114118
[TBL] [Abstract][Full Text] [Related]
14. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
Sousa AM; Monteiro R; Pereira MO
Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
[TBL] [Abstract][Full Text] [Related]
15. RhlR-Regulated Acyl-Homoserine Lactone Quorum Sensing in a Cystic Fibrosis Isolate of Pseudomonas aeruginosa.
Cruz RL; Asfahl KL; Van den Bossche S; Coenye T; Crabbé A; Dandekar AA
mBio; 2020 Apr; 11(2):. PubMed ID: 32265330
[TBL] [Abstract][Full Text] [Related]
16. Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum.
Turner KH; Wessel AK; Palmer GC; Murray JL; Whiteley M
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4110-5. PubMed ID: 25775563
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
18. Application of a quantitative framework to improve the accuracy of a bacterial infection model.
Lewin GR; Kapur A; Cornforth DM; Duncan RP; Diggle FL; Moustafa DA; Harrison SA; Skaar EP; Chazin WJ; Goldberg JB; Bomberger JM; Whiteley M
Proc Natl Acad Sci U S A; 2023 May; 120(19):e2221542120. PubMed ID: 37126703
[TBL] [Abstract][Full Text] [Related]
19. Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.
Mangiaterra G; Amiri M; Di Cesare A; Pasquaroli S; Manso E; Cirilli N; Citterio B; Vignaroli C; Biavasco F
BMC Infect Dis; 2018 Dec; 18(1):701. PubMed ID: 30587160
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
[No Abstract] [Full Text] [Related]
[Next] [New Search]
